29 Mar 2020

Remdesivir looms as most likely Covid-19 drug

From Sunday Morning, 8:47 am on 29 March 2020

Remdesivir, an investigational drug developed by Gilead Sciences Inc. as a general purpose anti-viral, is being billed as the most promising Covid-19 drug by researchers. Andrew Joseph is a reporter at STAT covering health and medicine who has been looking into Remdesivir, which is claimed to have aided the first confirmed U.S. coronavirus patient.

No caption